Lv3
400 积分 2023-05-10 加入
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
12天前
已完结
Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia
14天前
已关闭
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial
15天前
已关闭
Approaching a therapeutic inflection point for FLT3-mutated AML
15天前
已关闭
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
19天前
已完结
Biosimilar monoclonal antibodies for cancer treatment in adults
1个月前
已关闭
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2个月前
已完结
An Automated Culture System for Maintaining and Differentiating Human-Induced Pluripotent Stem Cells
2个月前
已关闭
P3.13D.11 SEZ6 Expression in Neuroendocrine Tumors
2个月前
已关闭
Honing CAR T cells to tackle acute myeloid leukemia
2个月前
已关闭
皖公网安备34019202002308
